The FDA has approved Pentacel (DTaP/IPV/Hib vaccine, from sanofi pasteur) for active immunization of children from 6 weeks through 4 years of age against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease due to Haemophilus influenzae type b. Pentacel is administered as a four-dose primary series that can reduce the total number of injections infants and children receive in their first two years of life.

For more information call (800) VACCINE or visit